VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 17, 2008) - Advanced Proteome Therapeutics Corporation (TSX VENTURE: APC) is pleased to announce that its subsidiary Advanced Proteome Therapeutics Inc. (APT) has achieved a major advance in the development of its core, proprietary technology, kinetic labelling libraries.
